Food and Drug Administration (FDA) officials delayed the approval decision deadline for Eli Lilly's (LLY) Alzheimer's drug, donanemab, as regulators carefully examine how the new treatment will compete and compare to other offerings in its drug class. Yahoo Finance Health Reporter Anjalee Khemlani helps explain. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Luke Carberry Mogan.
Food and Drug Administration (FDA) officials delayed the approval decision deadline for Eli Lilly's (LLY) Alzheimer's drug, donanemab, as regulators carefully examine how the new treatment will compete and compare to other offerings in its drug class.
Yahoo Finance Health Reporter Anjalee Khemlani helps explain.
For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
Editor's note: This article was written by Luke Carberry Mogan.
Associated Press Finance
The maker of a much-debated drug for Lou Gehrig’s disease said Friday its therapy failed to help patients in a large follow-up study, but stopped short of committing to follow through on a prior pledge to pull the drug from the U.S. market. The Food and Drug Administration approved Amylyx Pharmaceuticals’ Relyvrio in September 2022, following a years-long advocacy campaign by patients with amyotrophic lateral sclerosis, or ALS, a fatal muscle-wasting disease. Amylyx said Friday it would discuss its plans for Relyvrio with patients and the FDA, which “may include voluntarily withdrawing” the drug.
Reuters
(Reuters) -A federal appeals court has upheld a Texas law mandating that pornography websites verify that their users are adults, though it struck down a part of the law requiring them to display health warnings about their content. The 2-1 decision from the New Orleans-based 5th U.S. Circuit Court of Appeals late on Thursday overturned a lower court ruling blocking the law, which had been challenged in court by pornography producers. Adult industry group Free Speech Coalition, which is spearheading the lawsuit, said in a statement that it "strenuously" disagrees with the ruling and is considering its next steps.